Sino Biopharmaceutical Ltd. is a diversified biopharmaceutical enterprise specializing in the research, development, manufacturing, and commercialization of a wide array of pharmaceuticals. The compan... Sino Biopharmaceutical Ltd. is a diversified biopharmaceutical enterprise specializing in the research, development, manufacturing, and commercialization of a wide array of pharmaceuticals. The company's primary focus lies in four major categories: modernized Chinese medicines, chemical drugs, biotechnological drugs, and healthcare products. These products are pivotal in treating and preventing various diseases, with a significant emphasis on cancer, hepatitis, and cardiovascular disorders. With a strong presence in the Asian pharmaceutical industry, Sino Biopharmaceutical Ltd. plays a crucial role in enhancing healthcare through innovative drug solutions. The company invests heavily in research and development to introduce new, effective treatments and maintains a dynamic portfolio that matches the evolving medical needs of the global market. By leveraging its extensive distribution network, Sino Biopharmaceutical Ltd. ensures its products reach a wide range of healthcare institutions, thus contributing significantly to public health advancement. Headquartered in Hong Kong, the company's commitment to excellence and accessibility in healthcare makes it a key player in the industry.
Pending data availability
EU Taxonomy Data missing for Sino Biopharmaceutical
We haven’t collected EU Taxonomy data for Sino Biopharmaceutical yet, or the company
hasn’t made it publicly available.